Universidad Nacional de Asunción Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2009
NCT02278913
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Facultad de Ciencias Médicas - Universidad Nacional de Asunción | Universidad Nacional de Asunción | Universida Nacional de Asuncion

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Hyperglycemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5